{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:37:44Z","timestamp":1780591064548,"version":"3.54.1"},"reference-count":121,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Society of Clinical Oncology Educational Book"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>Platinum-based chemotherapy has been the standard of care in advanced urothelial cancer, but long-term outcomes have remained poor. Immune checkpoint inhibitors, with their favorable toxicity profiles and noteworthy efficacy, have steered a new era in advanced urothelial cancer, with five agents targeting the PD-1\/PD-L1 pathway approved by the U.S. Food and Drug Administration (FDA). However, most patients do not achieve response, whereas immunotherapy-related adverse events may cause morbidity, increased health care use, and\u2014rarely\u2014mortality. Therefore, there is an urgent need for additional therapeutic modalities across the disease spectrum. A plethora of clinical trials are ongoing in various disease settings, including chemotherapy regimens, radiotherapy, antibody-drug conjugates, agents targeting additional immune checkpoint pathways, vaccine, cytokines, adoptive cell therapies, as well as targeted and anti-angiogenic agents. Two agents, enfortumab vedotin and erdafitinib, have breakthrough designation by the FDA but are not approved yet (at the time of this paper's preparation). Novel combinations with various treatment modalities and optimal sequencing of active therapies are being investigated in prospective clinical trials. Evaluation of new treatments has met with substantial challenges for many reasons, for example, molecular heterogeneity, clonal evolution, and genomic instability. In the era of precision molecular medicine, and because patients do not respond uniformly to current therapies, there is a growing need for identification and validation of biomarkers that can accurately predict treatment response and assist in patient selection. Here, we review current updates and future directions of experimental therapeutics in urothelial cancer, including examples (but not an exhaustive list) of ongoing clinical trials.<\/jats:p>","DOI":"10.1200\/edbk_237449","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T14:29:36Z","timestamp":1558103376000},"page":"284-300","source":"Crossref","is-referenced-by-count":14,"title":["Conceptual Framework for Therapeutic Development Beyond Anti\u2013PD-1\/PD-L1 in Urothelial Cancer"],"prefix":"10.1200","author":[{"given":"Petros","family":"Grivas","sequence":"first","affiliation":[{"name":"From the University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Drakaki","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence W.","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guru","family":"Sonpavde","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"bibr1-EDBK_237449","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"Sanli O","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"bibr2-EDBK_237449","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","volume":"30","author":"Hedegaard J","year":"2016","journal-title":"Cancer Cell"},{"key":"bibr3-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318376111"},{"key":"bibr4-EDBK_237449","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2017.03.010","volume":"72","author":"Choi W","year":"2017","journal-title":"Eur Urol"},{"key":"bibr5-EDBK_237449","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/1078-0432.CCR-18-2512","volume":"25","author":"Grivas P","year":"2019","journal-title":"Clin Cancer Res"},{"key":"bibr6-EDBK_237449","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"Sj\u00f6dahl G","year":"2012","journal-title":"Clin Cancer Res"},{"key":"bibr7-EDBK_237449","doi-asserted-by":"crossref","first-page":"38531","DOI":"10.1038\/srep38531","volume":"6","author":"Warrick JI","year":"2016","journal-title":"Sci Rep"},{"key":"bibr8-EDBK_237449","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.eururo.2018.06.047","volume":"74","author":"Hovelson DH","year":"2018","journal-title":"Eur Urol"},{"key":"bibr9-EDBK_237449","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.eururo.2018.12.005","volume":"75","author":"Zahoor H","year":"2019","journal-title":"Eur Urol"},{"key":"bibr10-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.039"},{"key":"bibr11-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 1516","DOI":"10.1200\/JCO.2018.36.15_suppl.1516","volume":"36","author":"Carlo MI","year":"2018","journal-title":"J Clin Oncol"},{"key":"bibr12-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.01.007"},{"key":"bibr13-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6795"},{"key":"bibr14-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2411"},{"key":"bibr15-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30065-7"},{"key":"bibr16-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00561-4"},{"key":"bibr17-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683"},{"key":"bibr18-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33297-X"},{"key":"bibr19-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32455-2"},{"key":"bibr20-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30616-2"},{"key":"bibr21-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01148"},{"key":"bibr22-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 4506","DOI":"10.1200\/JCO.2018.36.15_suppl.4506","volume":"36","author":"Powles T","year":"2018","journal-title":"J Clin Oncol"},{"key":"bibr23-EDBK_237449","volume-title":"ESMO 2018 Congress","author":"de Wit R","year":"2018"},{"key":"bibr24-EDBK_237449","volume-title":"Genitourinary Cancers Symposium","author":"Grivas P","year":"2019"},{"key":"bibr25-EDBK_237449","volume-title":"Genitourinary Cancers Symposium","author":"Grivas P","year":"2019"},{"key":"bibr26-EDBK_237449","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1038\/s41467-018-05992-x","volume":"9","author":"Wang L","year":"2018","journal-title":"Nat Commun"},{"key":"bibr27-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501"},{"key":"bibr28-EDBK_237449","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/annonc\/mdx405","volume":"28","author":"Barata PC","year":"2017","journal-title":"Ann Oncol"},{"key":"bibr29-EDBK_237449","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-018-0693-y","volume":"20","author":"Koshkin VS","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"bibr30-EDBK_237449","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2147\/TCRM.S158753","volume":"14","author":"Gopalakrishnan D","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"bibr31-EDBK_237449","author":"Schiff JP","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"bibr32-EDBK_237449","first-page":"917","volume":"60","author":"Yagoda A","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"bibr33-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.17.3068"},{"key":"bibr34-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3571"},{"key":"bibr35-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022148"},{"key":"bibr36-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.3139"},{"key":"bibr37-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.4785"},{"key":"bibr38-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2465"},{"key":"bibr39-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.08.032"},{"key":"bibr40-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.08.033"},{"key":"bibr41-EDBK_237449","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-018-2606-y","volume":"37","author":"Leow JJ","year":"2019","journal-title":"World J Urol"},{"key":"bibr42-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70275-8"},{"key":"bibr43-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 240","DOI":"10.1200\/jco.2011.29.7_suppl.240","volume":"29","author":"Feifer A","year":"2011","journal-title":"J Clin Oncol"},{"key":"bibr44-EDBK_237449","volume-title":"ESMO 2018 Congress","author":"Hoimes CJ","year":"2018"},{"key":"bibr45-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124"},{"key":"bibr46-EDBK_237449","volume-title":"2018 ASCO Annual Meeting","author":"Rosenberg JE","year":"2018"},{"key":"bibr47-EDBK_237449","doi-asserted-by":"crossref","unstructured":"Tagawa S, Faltas BM, Lam ET, et alSacituzumab govitecan (IMMU-132) in patients with previously treated urothelial cancer: results from a phase I\/II study. Presented at ASCO Genitourinary Symposium. San Francisco, CA; 2019.","DOI":"10.1200\/JCO.2019.37.7_suppl.354"},{"key":"bibr48-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-26-305-234"},{"key":"bibr49-EDBK_237449","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/jca.5046","volume":"4","author":"Ma Y","year":"2013","journal-title":"J Cancer"},{"key":"bibr50-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017"},{"key":"bibr51-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0272-1"},{"key":"bibr52-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"bibr53-EDBK_237449","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","volume":"229","author":"Croft M","year":"2009","journal-title":"Immunol Rev"},{"key":"bibr54-EDBK_237449","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5483\/BMBRep.2014.47.3.283","volume":"47","author":"Vinay DS","year":"2014","journal-title":"BMB Rep"},{"key":"bibr55-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12519"},{"key":"bibr56-EDBK_237449","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00262-018-2246-5","volume":"67","author":"Solomon BL","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"bibr57-EDBK_237449","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","volume":"74","author":"Lines JL","year":"2014","journal-title":"Cancer Res"},{"key":"bibr58-EDBK_237449","doi-asserted-by":"crossref","first-page":"E645","DOI":"10.3390\/ijms18030645","volume":"18","author":"Du W","year":"2017","journal-title":"Int J Mol Sci"},{"key":"bibr59-EDBK_237449","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.172.7.3983","volume":"172","author":"Nelson BH","year":"2004","journal-title":"J Immunol"},{"key":"bibr60-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 3006","DOI":"10.1200\/JCO.2018.36.15_suppl.3006","volume":"36","author":"Diab A","year":"2018","journal-title":"J Clin Oncol"},{"key":"bibr61-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"bibr62-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709684"},{"key":"bibr63-EDBK_237449","volume-title":"ESMO 2018 Congress","author":"Rosenberg JE","year":"2018"},{"key":"bibr64-EDBK_237449","doi-asserted-by":"crossref","first-page":"CT112","DOI":"10.1158\/1538-7445.AM2018-CT112","volume":"78","author":"Balar AV","year":"2018","journal-title":"Cancer Res"},{"key":"bibr65-EDBK_237449","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/cmi.2017.143","volume":"15","author":"Zhai L","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"bibr66-EDBK_237449","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1200\/JCO.2017.35.15_suppl.4503","volume":"35","author":"Smith DC","year":"2017","journal-title":"J Clin Oncol"},{"key":"bibr67-EDBK_237449","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.csbj.2015.03.008","volume":"13","author":"Leone RD","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"bibr68-EDBK_237449","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14737140.2017.1316197","volume":"17","author":"Whiteside TL","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"bibr69-EDBK_237449","first-page":"460654","volume":"2014","author":"Gao ZW","year":"2014","journal-title":"BioMed Res Int"},{"key":"bibr70-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0257-y"},{"key":"bibr71-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.007"},{"key":"bibr72-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.5740"},{"key":"bibr73-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.6067"},{"key":"bibr74-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.0218"},{"key":"bibr75-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32365-6"},{"key":"bibr76-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 349","DOI":"10.1200\/JCO.2017.35.6_suppl.349","volume":"35","author":"Petrylak DP","year":"2017","journal-title":"J Clin Oncol"},{"key":"bibr77-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3922"},{"key":"bibr78-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr023"},{"key":"bibr79-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28477"},{"key":"bibr80-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7002"},{"key":"bibr81-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2012.10.001"},{"key":"bibr82-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70294-2"},{"key":"bibr83-EDBK_237449","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clgc.2016.03.011","volume":"14","author":"Narayanan S","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"bibr84-EDBK_237449","volume-title":"Genitourinary Cancers Symposium","author":"Apolo AB","year":"2014"},{"key":"bibr85-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 293","DOI":"10.1200\/JCO.2017.35.6_suppl.293","volume":"35","author":"Apolo AB MA","year":"2017","journal-title":"J Clin Oncol"},{"key":"bibr86-EDBK_237449","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cncr.29826","volume":"122","author":"Ross JS","year":"2016","journal-title":"Cancer"},{"key":"bibr87-EDBK_237449","author":"Nassar AH","journal-title":"Clin Cancer Res"},{"key":"bibr88-EDBK_237449","first-page":"1","volume":"2","author":"Nassar AH","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"bibr89-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds486"},{"key":"bibr90-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.10.013"},{"key":"bibr91-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0229"},{"key":"bibr92-EDBK_237449","unstructured":"Siefker-Radtke AO, Necchi A, Park SH, et alRogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway. Presented at ASCO Annual Meeting. Chicago, IL; 2018."},{"key":"bibr94-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 4540","DOI":"10.1200\/JCO.2017.35.15_suppl.4540","volume":"35","author":"Bellmunt J","year":"2018","journal-title":"J Clin Oncol"},{"key":"bibr95-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr CT111","DOI":"10.1158\/0008-5472.CAN-16-3427","volume":"77","author":"Saleh M","year":"2017","journal-title":"Cancer Res"},{"key":"bibr96-EDBK_237449","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2017.35.15_suppl.2500","volume":"35","author":"Voss MH","year":"2017","journal-title":"J Clin Oncol"},{"key":"bibr97-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018583"},{"key":"bibr98-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1126\/science.1226344"},{"key":"bibr99-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0353"},{"key":"bibr100-EDBK_237449","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41416-018-0261-0","volume":"119","author":"Bellmunt J","year":"2018","journal-title":"Br J Cancer"},{"key":"bibr101-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn749"},{"key":"bibr102-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.9572"},{"key":"bibr103-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28767"},{"key":"bibr104-EDBK_237449","first-page":"362","volume":"3","author":"Grivas PD","year":"2011","journal-title":"Am J Transl Res"},{"key":"bibr105-EDBK_237449","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BLC-180196","volume":"5","author":"Koshkin VS","year":"2019","journal-title":"Bladder Cancer"},{"key":"bibr106-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.0994"},{"key":"bibr107-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.10.009"},{"key":"bibr108-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 348","DOI":"10.1200\/JCO.2017.35.6_suppl.348","volume":"35","author":"Bryce AH KR","year":"2017","journal-title":"J Clin Oncol"},{"key":"bibr109-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.3468"},{"key":"bibr110-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24337"},{"key":"bibr111-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.3047"},{"key":"bibr112-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 62","DOI":"10.1200\/JCO.2019.37.4_suppl.62","volume":"37","author":"Janjigian YY CJ","year":"2019","journal-title":"J Clin Oncol"},{"key":"bibr113-EDBK_237449","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/cncr.31314","volume":"124","author":"Agarwal N","year":"2018","journal-title":"Cancer"},{"key":"bibr114-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.7740"},{"key":"bibr115-EDBK_237449","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/CAD.0000000000000114","volume":"25","author":"Jian W","year":"2014","journal-title":"Anticancer Drugs"},{"key":"bibr116-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1038\/nature12965"},{"key":"bibr117-EDBK_237449","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1541-7786.MCR-17-0260","volume":"16","author":"Duex JE","year":"2018","journal-title":"Mol Cancer Res"},{"key":"bibr118-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31817"},{"key":"bibr119-EDBK_237449","doi-asserted-by":"crossref","first-page":"abstr 16058","DOI":"10.1200\/jco.2008.26.15_suppl.16058","volume":"26","author":"Cheung EM","year":"2008","journal-title":"J Clin Oncol"},{"key":"bibr120-EDBK_237449","doi-asserted-by":"crossref","first-page":"eaai8312","DOI":"10.1126\/scitranslmed.aai8312","volume":"9","author":"Ler LD","year":"2017","journal-title":"Sci Transl Med"},{"key":"bibr121-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3799"},{"key":"bibr122-EDBK_237449","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0229-0"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK_237449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:51:26Z","timestamp":1663480286000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK_237449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":121,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1200\/EDBK_237449"],"URL":"https:\/\/doi.org\/10.1200\/edbk_237449","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}